RNN Financial Facts

See Full Income Statement

See Full Balance Sheet

Rexahn Pharmaceuticals (RNN) Earnings

  |   Expand Research on RNN
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +41.7% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS 0.0% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/8/16 Q216 -$0.01-$0.02 +$0.01N/AN/A N/A Details
5/9/16 Q116 -$0.02N/A N/A N/AN/A N/A Details
11/3/15 Q315 -$0.02-$0.03 +$0.01N/AN/A N/A Details
8/10/15 Q215 -$0.02N/A N/A N/AN/A N/A Details
5/11/15 Q115 -$0.02-$0.03 +$0.01N/AN/A N/A Details
11/12/14 Q314 -$0.01-$0.02 +$0.01N/AN/A N/A Details
8/14/14 Q214 $0.00-$0.02 +$0.02N/AN/A N/A Details
5/14/14 Q114 -$0.09-$0.02 -$0.07N/AN/A N/A Details